Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer
Qiaoqi Chen, Liang Zhang, Lin Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 117
Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy
Namdev Dhas, Mónica Cristina García, Ritu Kudarha, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 71-97
Closed Access | Times Cited: 69
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 23
Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles
Serkan Yaman, Harish Ramachandramoorthy, Priyanka Raghunathan Iyer, et al.
Bioactive Materials (2024) Vol. 34, pp. 422-435
Open Access | Times Cited: 14
Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy
Amit Kumar Rajora, Eknath D. Ahire, Manju A. K. Rajora, et al.
Smart Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform
Qiuyan Guo, Shengmei Wang, Rubing Xu, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10608-10637
Open Access | Times Cited: 14
“Nanodecoys” - Future of drug delivery by encapsulating nanoparticles in natural cell membranes
Mohammad Imran, Laxmi Akhileshwar Jha, Nazeer Hasan, et al.
International Journal of Pharmaceutics (2022) Vol. 621, pp. 121790-121790
Closed Access | Times Cited: 42
Progress in the preparation of Prussian blue-based nanomaterials for biomedical applications
Kun Lü, Xiaoyang Zhu, Yan Li, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 24, pp. 5272-5300
Open Access | Times Cited: 34
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 31
Recent advances in Prussian blue-based photothermal therapy in cancer treatment
Kaiyuan Tang, Xiao Li, Yanling Hu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 13, pp. 4411-4429
Closed Access | Times Cited: 26
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 26
Genetically engineered cellular nanoparticles for biomedical applications
Nishta Krishnan, Fei-Xing Peng, Animesh Mohapatra, et al.
Biomaterials (2023) Vol. 296, pp. 122065-122065
Open Access | Times Cited: 22
Self-assembled albumin nanoparticles induce pyroptosis for photodynamic/photothermal/immuno synergistic therapies in triple-negative breast cancer
Jianquan Yang, Wen Guo, Rong Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting
Huachun Pan, Shumin Yang, Lun Gao, et al.
Coordination Chemistry Reviews (2024) Vol. 506, pp. 215712-215712
Closed Access | Times Cited: 13
Homologous Tumor Targeting Molybdenum‐Doped Prussian Blue for Enhancing Immunotherapy via PTT/CDT and Remodeled Tumor Immune Microenvironment
Shuaining Ma, Dan Li, Xiuna Jia, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 9
Mitochondria targeted biomimetic platform for chemo/photodynamic combination therapy against osteosarcoma
Fengtian Zhang, Jiaoting Chen, Weihong Luo, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123865-123865
Closed Access | Times Cited: 7
Photoluminescent assay and imaging for effective modulation of photothermal events on enhanced cancer therapy developed via analytical techniques
Tianyou Wang, Hang Zhang, Zhaoyin Wang, et al.
TrAC Trends in Analytical Chemistry (2025), pp. 118188-118188
Closed Access
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 15
Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
Xiaoxue Lang, Xiangtao Wang, Meihua Han, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4533-4568
Open Access | Times Cited: 6
Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy
Zichen Zhong, Wen Deng, Jian Wu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8708-8738
Closed Access | Times Cited: 5
Ultrasound-triggered drug-loaded nanobubbles for enhanced T cell recruitment in cancer chemoimmunotherapy
Deng Liu, Yi Ling, Li Dong, et al.
Biomaterials (2025) Vol. 317, pp. 123086-123086
Closed Access
Versatile PLGA‐Based Drug Delivery Systems for Tumor Immunotherapy
Yishu Wang, Xiaoming Hu, Jinghui Wang, et al.
Small Methods (2025)
Closed Access
Cell membrane-camouflaged nanocarriers: A cutting-edge biomimetic technology to develop cancer immunotherapy
Rajkumar Samanta, Niladri Haldar, Anchal Pamecha, et al.
International Journal of Pharmaceutics (2025) Vol. 672, pp. 125336-125336
Closed Access
Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy
Jiayi Zhang, Fang Wang, Zhaogang Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Nanotechnology-based cell-mediated delivery systems for cancer therapy and diagnosis
Vahid Alimardani, Zahra Rahiminezhad, Mahvash Dehghankhold, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 1, pp. 189-221
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top